China High Purity Oyster Peptide Powder Oyster Extract Oyster Peptide, Find details about China Extract Powder Oyster Peptide, Oyster Peptide Enhancement from High Purity Oyster Peptide Powder Oyster Extract Oyster Peptide
Group | Serum T3(ng/L) | SerumT4(ng/L) | Serum TSH (mU/L) | Expression of thyroid stimulating hormone releasing hormone (TRH) mRNA in hypothalamus(%) |
Normal group | 32 | 57 | 3.2 | 10.5 |
Model group | 22 | 38 | 4.3 | 5.4 |
Low dose group | 25 | 40 | 4.2 | 6 |
Medium dose group | 28 | 42 | 3.6 | 6.6 |
High dose group | 30 | 50 | 3.4 | 8.4 |
Group | Thymus / Body Mass C/mgg-1 | Spleen / Body Mass C/mgg-1 | Total protein C/g L-1 | Albumin C/g L-1 |
Normal group | 1.68±0.21 | 4.36±0.33 | 58.36±3.64 | 32.69±1.34 |
Model group | 1.70±0.19 | 4.39±0.25 | 60.69±3.53 | 33.19±1.95 |
Low dose group | 1.68±0.20 | 4.36±0.28 | 64.54±5.61⋆ | 34.25±1.31 |
Medium dose group | 1.69±0.24 | 4.37±0.31 | 61.95±3.85⋆ | 42.95±1.28⋆ |
High dose group | 1.73±0.25 | 4.40±0.29 | 60.35±8.51 | 38.47±2.95⋆ |
Test Items | Quality Standard |
Total Protein (Dry Basis) | ≥70% |
Peptides (Dry Basis) | ≥60% |
The relative molecular weight of protein hydrolysate below 1000 Dalton | ≥80% |
Moisture | ≤7.0% |
Ash | ≤8.0% |
Total Plate Count, CFU/g | ≤10000 |
Coliform, MPN/100g | ≤92 |
Yeasts and molds, CFU/g | ≤50 |
Pathogenic bacteria (Salmonella, Shigilla, ) | None |
Lead(Pb), mg/kg | ≤0.5 |
Arsenic(As), mg/kg | ≤0.5 |